Abstract

The incidence of thyroid cancer (TC) is increasing although explanatory causes are lacking. A link between cancer and inflammation is well documented but unclear for autoimmune thyroid diseases and TC. We aimed to systematically review the association between Hashimoto's thyroiditis (HT) and papillary, follicular, medullary, anaplastic thyroid carcinoma, and thyroid lymphoma (TL). PubMed, OVID Medline, Google Scholar, and the Cochrane Library were searched from 1955 to 2016. The inclusion criteria were age >18 years, ≥20 cases of HT or TC. We collectively examined the incidence of HT in TC and of TC in HT. We identified 36 studies (64,628 subjects) published between 1955 and 2016 from 13 countries. We found a relative risk (RR) of HT among papillary thyroid cancer (PTC) of 2.36 [95% confidence intervals (CIs) 1.55-3.29, p < 0.001], an RR of PTC among HT of 1.40 (95% CI 1.07-1.85, p = 0.016), and an RR of TL among HT of 9.74 (95% CI 3.93-24.13, p < 0.001). We report an association between HT and PTC and between HT and TL. No association was found between HT and follicular, medullary, or anaplastic thyroid cancer.

Highlights

  • Thyroid cancer (TC) is the most common endocrine malignancy, and the incidence has been increasing worldwide during the last decades [1,2,3,4,5]

  • We found a relative risk (RR) of Hashimoto’s thyroiditis (HT) among papillary thyroid cancer (PTC) of 2.36 [95% confidence intervals (CIs) 1.55–3.29, p < 0.001], an RR of Papillary thyroid carcinoma (PTC) among HT of 1.40, and an RR of Thyroid lymphoma (TL) among HT of 9.74

  • We present the first systematic review on the association between HT and five types of TC, and the largest review on HT and PTC examining both HT and TC patient groups

Read more

Summary

Introduction

Thyroid cancer (TC) is the most common endocrine malignancy, and the incidence has been increasing worldwide during the last decades [1,2,3,4,5]. Papillary thyroid carcinoma (PTC) (70–80% of all TCs), follicular thyroid carcinoma (FTC) (10–20% of all TCs), medullary thyroid carcinoma (MTC) (5–8% of all TCs), and anaplastic thyroid carcinoma (ATC) (

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.